uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now

BOSTON, Mass. – October 10, 2022 — uMotif, one of the clinical research technology market’s fastest growing companies, will share its unique perspective on how pharma and biotech can and must adopt market-tested eCOA/ePRO solutions that engage patients to run better trials and real-world studies at top industry events during Q4…

• Pharma 2022, Nice Acropolis Convention Center Exhibit in Nice, France, October 11-13
• North Carolina Biosciences Organization Annual Meeting, NC Biotech Center in Research Triangle Park, NC, October 12
• Outsourcing in Clinical Trials New England, Westin Boston Seaport District Hotel in Boston, MA, October 12-13

• ISPOR Europe, Austria Center Vienna in Vienna, Austria and online, November 6-9
• Data Management Biomedical, Cité Universitaire Internationale in Paris, France, November 14
• CNS Summit 2022, Boca Raton Hotel, in Boca Raton, FL, November 17-20, (Sponsor) – uMotif CEO Steve Rosenberg (LinkedIn) will lead a panel discussion on the path to true patient engagement
• North Carolina Biosciences Organization Clinical Trials Forum, NC Biotech Center in Research Triangle Park, NC, November 29

• IDF Lisbon, Centro de Congressos de Lisboa CCL, in Lisbon, Spain and online, December 5-8 – On December 6, uMotif Chief Patient Officer and Co-Founder Bruce Hellman (LinkedIn) will participate in a panel discussion on PROMS in diabetes care, in the Healthcare Track

To arrange a personal meeting with a uMotif executive at any of these events, email